Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
12/27/1990 | EP0403541A1 Immunogenic glycoproteins of human cytomegalovirus |
12/27/1990 | EP0403524A1 Preparation of nitruro compounds usable as radio-pharmaceutical products. |
12/27/1990 | EP0229108B1 Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
12/27/1990 | EP0214995B1 Immunotoxin and method of making |
12/27/1990 | EP0120958B1 Characterization of oncogenes and assays based thereon |
12/27/1990 | CA2388770A1 Platelet aggregation inhibitors |
12/27/1990 | CA2066692A1 Gamma retinoic acid receptor |
12/27/1990 | CA2063414A1 Vector-mediated genomic insertion and expression of dna in bcg |
12/27/1990 | CA2062741A1 Methods, compositions and devices for growing cells |
12/27/1990 | CA2058999A1 Contraceptive vaccine based on cloned zona pellucida gene |
12/27/1990 | CA2019845A1 Compounds |
12/27/1990 | CA2019714A1 Process for the determination of interleukins |
12/27/1990 | CA1278227C Method for producing small, spherical polymer particles |
12/26/1990 | CA2019696A1 Control of aberrant expression vector accumulation during fermentation procedures |
12/26/1990 | CA2019665A1 Hybrid proteins between an extracytoplasmic enzyme and at least another protein, processes for preparing them and their applications |
12/25/1990 | US4980457 Coupling of ricin and antibody |
12/25/1990 | US4980456 Recombinant factor VIIIC derived fragments |
12/25/1990 | US4980455 Novel polypeptides and production thereof |
12/25/1990 | US4980450 Phosphopeptides from casein-based raw material |
12/25/1990 | US4980286 In vivo introduction and expression of foreign genetic material in epithelial cells |
12/25/1990 | US4980279 Synthtic polypeptide corresponds in sequence to a portion of amino acid residue of human cellular fibronectin |
12/25/1990 | US4980166 Administering follicle-stimulating hormone |
12/25/1990 | US4980161 Applying animal interferon |
12/25/1990 | CA2019661A1 Modified vp1/p2a region of the rhinovirus system |
12/24/1990 | WO1991000361A1 Efficient method for identifiable expression of non-selectable genes |
12/24/1990 | WO1991000105A1 Vaccine against bovine leukemia virus |
12/24/1990 | CA2033071A1 Bovine leukemia virus vaccine |
12/22/1990 | WO1990015872A1 Recombinant poxvirus and streptococcal m protein vaccine |
12/22/1990 | CA2019215A1 Recombinant avipoxvirus |
12/20/1990 | WO1990015625A1 RADIOIMMUNOTHERAPY USING α-PARTICLES EMISSION |
12/20/1990 | DE3919915A1 Aminoalkylmaleimide und davon abgeleitete hapten- und antigenderivate sowie konjugate mit peptiden oder proteinen Aminoalkylmaleimide and derived hapten and antigen derivatives and conjugates with peptides or proteins |
12/19/1990 | EP0403458A1 Novel polypeptides and their use |
12/19/1990 | EP0403333A2 Nucleotide sequences of retroviral genomes of types HIV-I, HIV-2 and SIV, their uses for the amplification of these genomes and diagnosis in vitro of these viral infections |
12/19/1990 | EP0403312A1 Immunoactive peptides and antibodies and their use in anti-allergy treatment |
12/19/1990 | EP0403243A1 Chelate derivatives of atrial natriuretic factor (ANF) |
12/19/1990 | EP0403172A2 Purified enzyme and process therefor |
12/19/1990 | EP0403156A1 Improved monoclonal antibodies against the human alpha/beta t-cell receptor, their production and use |
12/19/1990 | EP0403114A1 Interleukin-7 receptors |
12/19/1990 | EP0402699A2 Chromogenic dibenzoxazepinone and dibenzothiazepinone enzyme substrates |
12/19/1990 | EP0402544A1 Nucleotide sequence encoding plant ribosome inactivating protein |
12/19/1990 | EP0402354A1 Molecular cloning of human rotavirus serotype 4 gene 9 encoding vp7, the major outer capsid neutralisation specific glycoprotein and expression of vp7 and fragments thereof for use in a vaccine |
12/19/1990 | CN1047870A Renin-inhibiting peptides, processes for their preparation and their use in medicaments |
12/19/1990 | CA2019323A1 Chimeric mouse-human km10 antibody with specificity to a human tumor cell antigen |
12/19/1990 | CA2019239A1 Ovine follicle stimulating hormone |
12/19/1990 | CA2019217A1 Magnetic protein conjugates, a process for the preparation thereof and the use thereof |
12/18/1990 | US4978745 Immunoreactive heterochain antibodies |
12/18/1990 | US4978623 Bacillus thuringiensis israelensis plasmid contains dna sequence which encodes insecticidal polypeptide |
12/18/1990 | US4978621 Merozoite surface antigens |
12/18/1990 | US4978616 Fluidized cell cultivation process |
12/18/1990 | US4978609 Monoclonal antibody specific to human pancreatic phospholipase A2 |
12/18/1990 | CA1278150C Carboxyalkyldipeptides, their preparation and pharmaceutical compositions containing them |
12/18/1990 | CA1277934C Hybrid cells producing an antibody characteristic of the hepatitis b virus from hepatocytes and established cells of monkey, process for obtaining such hybrid cells and application thereof for the production of the antigens aforementioned |
12/18/1990 | CA1277933C Porcine growth hormone analogs |
12/18/1990 | CA1277932C Human calcitonin precursor polyprotein structural gene |
12/17/1990 | WO1990015860A1 Dna sequences, vectors, and fusion polypeptides to increase secretion of desired polypeptides from filamentous fungi |
12/17/1990 | WO1990015821A1 Stabilized, potent grf analogs |
12/17/1990 | WO1990015808A1 Radionuclide metal chelates for the radiolabeling of proteins |
12/17/1990 | CA2057895A1 Stabilized, potent grf analogs |
12/16/1990 | WO1990015878A1 Immunoactive peptides and antibodies and their use in anti-allergy treatment |
12/16/1990 | WO1990015870A1 Interleukin-7 receptors |
12/16/1990 | WO1990015613A1 Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions |
12/16/1990 | CA2033082A1 Interleukin-7 receptors |
12/15/1990 | WO1990015525A1 Media for cell growth and method for making them |
12/14/1990 | WO1990015820A1 Peptides and antibodies derived therefrom for the diagnosis of, therapy for and vaccination against htlv-1 infection |
12/14/1990 | CA2062713A1 Peptides and antibodies derived therefrom for the diagnosis of, therapy for and vaccination against htlv-1 infection |
12/13/1990 | WO1990015158A1 Nucleotide sequences for the amplification of the hiv-2 and siv type retrovirus genome, and their applications in in vitro diagnosis of infections caused by these viruses |
12/13/1990 | WO1990015154A1 Human lymphoma-associated virus |
12/13/1990 | WO1990015150A1 Process for obtaining a regulation protein (nef) for hiv-1 using the human cell line th4-7-5 |
12/13/1990 | WO1990015143A1 Modified strains of phytopathogenic bacteria and their application in agriculture |
12/13/1990 | WO1990015141A2 Self-assembled, defective, non-self-propagating viral particles |
12/13/1990 | WO1990015138A1 Recombinant rhizobium bacteria inoculants |
12/13/1990 | WO1990015134A1 Catalytic antibodies |
12/13/1990 | WO1990015133A1 Method of producing core structure of retro virus and particle produced thereby |
12/13/1990 | WO1990015132A2 Cloned treponema hyodysenteriae endoflagellar antigen |
12/13/1990 | WO1990015077A1 Monoclonal antibody specific for bacterial transport proteins, and antibody-containing deodorant composition |
12/13/1990 | WO1990015075A1 HTLV-1 ENV GENE PRODUCTS EXPRESSED IN $i(E. COLI) |
12/13/1990 | WO1990015074A1 Methods for enhancing the rate of modification of metastable bonds |
12/13/1990 | WO1990015072A1 Platelet aggregation inhibitors and related molecules |
12/13/1990 | WO1990015070A1 Very large scale immobilized peptide synthesis |
12/13/1990 | WO1990015066A2 Nucleotidic sequences resulting from the retrovirus gemone of the hiv-1, hiv-2, and siv type, and their applications, in particular for the amplification of the genomes of said retroviruses and for the in vitro diagnosis of infections caused by these viruses |
12/13/1990 | WO1990014881A2 Chelating agents for attaching metal ions to proteins |
12/13/1990 | WO1990013644A3 Soluble cytoplasmic domain of human cd2 receptor |
12/13/1990 | DE3922089A1 Neue proteine und ihre herstellung New proteins and their production |
12/13/1990 | CA2685262A1 Nucleotides sequences derived from the genome of type hiv-1, hiv-2 and siv retroviruses, and their applications especially for the amplification the genomes of these retroviruses and for in vitro diagnosis of infections due to these viruses |
12/13/1990 | CA2391491A1 Very large scale immobilized peptide synthesis |
12/13/1990 | CA2033086A1 Chelating agents for attaching metal ions to proteins |
12/12/1990 | EP0402313A1 Novel endothelin derivative |
12/12/1990 | EP0402300A2 Production of bacteria and yeast of hemoglobin and analogues thereof |
12/12/1990 | EP0402226A1 Transformation vectors for yeast yarrowia |
12/12/1990 | EP0402205A1 Process for the preparation of purified albumin solutions |
12/12/1990 | EP0402159A1 Polypeptide having thrombin inhibiting activity and process for the manufacture thereof |
12/12/1990 | EP0402116A1 Proteins, vaccines and nucleic acids |
12/12/1990 | EP0402109A1 Low closure force EMI/RFI shielded door |
12/12/1990 | EP0402088A2 Conjugate immunogen for aids |
12/12/1990 | EP0402070A1 Crystalline r-h-GM-CSF and method for its preparation |
12/12/1990 | EP0402068A1 Polypeptides and polypeptide analogues with inhibitory activity against human elastase |
12/12/1990 | EP0402029A2 Monoclonal antibodies for post exposure treatment of rabies |
12/12/1990 | EP0401997A1 Process to prepare metastasis-inhibitory factor |
12/12/1990 | EP0401979A2 Novel bacillus thuringiensis isolates active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins |
12/12/1990 | EP0401963A1 Phosphonopeptides with collagenase inhibiting activity |